Lakeview Capital Partners LLC Invests $127,000 in Aurora Cannabis Inc (ACB)
Lakeview Capital Partners LLC bought a new position in shares of Aurora Cannabis Inc (NYSE:ACB) in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor bought 13,972 shares of the company’s stock, valued at approximately $127,000.
Several other hedge funds have also made changes to their positions in the company. Moloney Securities Asset Management LLC raised its stake in shares of Aurora Cannabis by 13.9% during the 1st quarter. Moloney Securities Asset Management LLC now owns 12,320 shares of the company’s stock worth $112,000 after buying an additional 1,500 shares during the period. US Bancorp DE raised its stake in shares of Aurora Cannabis by 30.8% during the 1st quarter. US Bancorp DE now owns 6,385 shares of the company’s stock worth $58,000 after buying an additional 1,505 shares during the period. Focused Wealth Management Inc raised its stake in shares of Aurora Cannabis by 33.6% during the 1st quarter. Focused Wealth Management Inc now owns 6,574 shares of the company’s stock worth $60,000 after buying an additional 1,654 shares during the period. Griffin Asset Management Inc. raised its stake in shares of Aurora Cannabis by 13.8% during the 1st quarter. Griffin Asset Management Inc. now owns 16,176 shares of the company’s stock worth $147,000 after buying an additional 1,960 shares during the period. Finally, Farmers & Merchants Trust Co of Chambersburg PA increased its position in shares of Aurora Cannabis by 27.7% during the first quarter. Farmers & Merchants Trust Co of Chambersburg PA now owns 9,220 shares of the company’s stock worth $84,000 after purchasing an additional 2,000 shares in the last quarter. 8.09% of the stock is owned by institutional investors and hedge funds.
ACB traded up $0.06 during mid-day trading on Friday, hitting $8.31. 7,456,131 shares of the stock were exchanged, compared to its average volume of 26,323,482. Aurora Cannabis Inc has a 1-year low of $4.05 and a 1-year high of $12.52. The company has a current ratio of 2.37, a quick ratio of 1.98 and a debt-to-equity ratio of 0.10. The firm has a market cap of $8.43 billion, a price-to-earnings ratio of 69.25 and a beta of 2.82.
Aurora Cannabis Profile
Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.
Read More: Back-End Load
Want to see what other hedge funds are holding ACB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aurora Cannabis Inc (NYSE:ACB).
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.